Cancer Family
Stromal Neoplasm
CI-CAN-00000360Explore in graph →
Non-malignant52 active trials2 approved drugs89 evidence items
- NCIt
- C6781
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000360Explore in graph →
Clinical trials
355 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00025246 | Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery | completed | Phase 2 | 89 | National Cancer Institute (NCI)NIH | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00005862 | SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00025415 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT01774162 | EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration | completed | N/A | 57 | University of AlbertaOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00005597 | S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors | completed | Phase 2 | 25 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 3, 2013 | clinicaltrials |
| NCT01270984 | Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects(Imatinib) | completed | Phase 1 | 30 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Oct 31, 2012 | clinicaltrials |
| NCT00003939 | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 132 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Sep 24, 2012 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00171977 | Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) | completed | Phase 4 | 64 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00507273 | Gastrointestinal Stromal Tumors (GIST) Registry | completed | — | 1,800 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00041249 | Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | 64 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00385203 | The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). | completed | Phase 2 | 35 | AstraZenecaINDUSTRY | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00471328 | Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib(ENEST) | completed | Phase 3 | 248 | Novartis PharmaceuticalsINDUSTRY | 13 | Jun 12, 2012 | clinicaltrials |
| NCT00004895 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004911 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00237172 | Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) | completed | Phase 2 | 72 | Novartis PharmaceuticalsINDUSTRY | 0 | May 1, 2012 | clinicaltrials |
| NCT00112632 | Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor | completed | Phase 2 | 40 | Technical University of MunichOTHER | 2 | Mar 8, 2012 | clinicaltrials |
| NCT01091207 | Sorafenib for Imatinib/Sunitinib-failed GIST | completed | Phase 2 | 39 | Samsung Medical CenterOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01246843 | Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib | completed | — | 50 | Radboud University Medical CenterOTHER | 1 | Nov 2, 2011 | clinicaltrials |
| NCT00564265 | Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo | completed | — | 24 | Cirujanos la SerenaOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT00500188 | Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST | completed | Phase 2 | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT00940563 | A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors | completed | Phase 2 | 135 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT01114087 | Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility(GLIFERTI) | completed | N/A | 2 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 29, 2011 | clinicaltrials |
| NCT00276302 | Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) | completed | Phase 1 | 63 | Infinity Pharmaceuticals, Inc.INDUSTRY | 2 | Jan 6, 2011 | clinicaltrials |
| NCT00069940 | Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | completed | Phase 1 | — | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT00877045 | Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting | completed | — | 200 | SCRI Development Innovations, LLCOTHER | 1 | Aug 4, 2010 | clinicaltrials |
| NCT00979381 | Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor | completed | — | 75 | Radboud University Medical CenterOTHER | 1 | Mar 18, 2010 | clinicaltrials |
| NCT00457743 | A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST) | completed | Phase 1 / Phase 2 | 36 | PfizerINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00075218 | A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) | completed | Phase 3 | 361 | PfizerINDUSTRY | 11 | Sep 28, 2009 | clinicaltrials |
| NCT00137449 | Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor | completed | Phase 2 | 60 | PfizerINDUSTRY | 3 | Sep 15, 2009 | clinicaltrials |
| NCT00041808 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 20 | FeRxINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Feb 20, 2013source: clinicaltrials